| Source | Evidence on protein | Close homologs |
|---|---|---|
| Cuervo et al. | no | yes: 0 |
| Hassani et al. | no | yes: 0 |
| Forrest at al. (metacyclic) | no | yes: 0 |
| Forrest at al. (procyclic) | no | yes: 0 |
| Silverman et al. | no | yes: 0 |
| Pissara et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Pires et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Silverman et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| Jamdhade et al. | no | yes: 0 |
| Source | Evidence on protein | Close homologs |
|---|---|---|
| DeepLoc | ||
| SignalP6 | no | yes: 0, no: 11 |
| NetGPI | no | yes: 0, no: 11 |
Related structures:
AlphaFold database: A0A3S5H7B7
| Leishmania | From | To | Domain/Motif | Score |
|---|---|---|---|---|
| CLV_C14_Caspase3-7 | 262 | 266 | PF00656 | 0.589 |
| CLV_C14_Caspase3-7 | 55 | 59 | PF00656 | 0.509 |
| CLV_NRD_NRD_1 | 10 | 12 | PF00675 | 0.511 |
| CLV_NRD_NRD_1 | 92 | 94 | PF00675 | 0.565 |
| CLV_PCSK_FUR_1 | 89 | 93 | PF00082 | 0.692 |
| CLV_PCSK_KEX2_1 | 187 | 189 | PF00082 | 0.621 |
| CLV_PCSK_KEX2_1 | 91 | 93 | PF00082 | 0.621 |
| CLV_PCSK_PC1ET2_1 | 187 | 189 | PF00082 | 0.691 |
| CLV_PCSK_SKI1_1 | 65 | 69 | PF00082 | 0.544 |
| DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.355 |
| DOC_CYCLIN_yClb3_PxF_3 | 224 | 230 | PF00134 | 0.512 |
| DOC_CYCLIN_yCln2_LP_2 | 205 | 211 | PF00134 | 0.629 |
| DOC_CYCLIN_yCln2_LP_2 | 222 | 225 | PF00134 | 0.487 |
| DOC_MAPK_gen_1 | 187 | 194 | PF00069 | 0.531 |
| DOC_MAPK_MEF2A_6 | 187 | 196 | PF00069 | 0.552 |
| DOC_MAPK_MEF2A_6 | 92 | 101 | PF00069 | 0.531 |
| DOC_PP2B_LxvP_1 | 156 | 159 | PF13499 | 0.594 |
| DOC_PP2B_LxvP_1 | 205 | 208 | PF13499 | 0.629 |
| DOC_PP2B_LxvP_1 | 222 | 225 | PF13499 | 0.487 |
| DOC_USP7_MATH_1 | 292 | 296 | PF00917 | 0.573 |
| DOC_USP7_UBL2_3 | 183 | 187 | PF12436 | 0.656 |
| DOC_WW_Pin1_4 | 134 | 139 | PF00397 | 0.496 |
| DOC_WW_Pin1_4 | 200 | 205 | PF00397 | 0.556 |
| LIG_14-3-3_CanoR_1 | 125 | 129 | PF00244 | 0.508 |
| LIG_14-3-3_CanoR_1 | 151 | 157 | PF00244 | 0.621 |
| LIG_14-3-3_CanoR_1 | 181 | 186 | PF00244 | 0.633 |
| LIG_14-3-3_CanoR_1 | 309 | 314 | PF00244 | 0.603 |
| LIG_Actin_WH2_2 | 50 | 67 | PF00022 | 0.353 |
| LIG_APCC_ABBA_1 | 108 | 113 | PF00400 | 0.519 |
| LIG_FHA_1 | 169 | 175 | PF00498 | 0.671 |
| LIG_FHA_2 | 195 | 201 | PF00498 | 0.405 |
| LIG_FHA_2 | 260 | 266 | PF00498 | 0.571 |
| LIG_LIR_Apic_2 | 133 | 138 | PF02991 | 0.480 |
| LIG_LIR_Gen_1 | 218 | 228 | PF02991 | 0.470 |
| LIG_LIR_Gen_1 | 254 | 263 | PF02991 | 0.464 |
| LIG_LIR_Gen_1 | 58 | 68 | PF02991 | 0.452 |
| LIG_LIR_Nem_3 | 113 | 117 | PF02991 | 0.353 |
| LIG_LIR_Nem_3 | 218 | 223 | PF02991 | 0.452 |
| LIG_LIR_Nem_3 | 254 | 259 | PF02991 | 0.489 |
| LIG_LIR_Nem_3 | 5 | 10 | PF02991 | 0.361 |
| LIG_LIR_Nem_3 | 58 | 63 | PF02991 | 0.401 |
| LIG_PCNA_PIPBox_1 | 1 | 10 | PF02747 | 0.368 |
| LIG_PTB_Apo_2 | 67 | 74 | PF02174 | 0.546 |
| LIG_SH2_GRB2like | 117 | 120 | PF00017 | 0.494 |
| LIG_SH2_STAP1 | 111 | 115 | PF00017 | 0.355 |
| LIG_SH2_STAP1 | 117 | 121 | PF00017 | 0.382 |
| LIG_SH2_STAP1 | 60 | 64 | PF00017 | 0.532 |
| LIG_SH2_STAT3 | 117 | 120 | PF00017 | 0.494 |
| LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.381 |
| LIG_SH2_STAT5 | 256 | 259 | PF00017 | 0.455 |
| LIG_SH2_STAT5 | 7 | 10 | PF00017 | 0.382 |
| LIG_SH3_3 | 218 | 224 | PF00018 | 0.392 |
| LIG_SH3_3 | 231 | 237 | PF00018 | 0.368 |
| LIG_SH3_3 | 94 | 100 | PF00018 | 0.522 |
| LIG_TRFH_1 | 220 | 224 | PF08558 | 0.466 |
| LIG_TYR_ITSM | 3 | 10 | PF00017 | 0.370 |
| MOD_CK1_1 | 77 | 83 | PF00069 | 0.678 |
| MOD_CK2_1 | 141 | 147 | PF00069 | 0.466 |
| MOD_CK2_1 | 194 | 200 | PF00069 | 0.385 |
| MOD_GlcNHglycan | 105 | 108 | PF01048 | 0.405 |
| MOD_GlcNHglycan | 143 | 146 | PF01048 | 0.532 |
| MOD_GlcNHglycan | 183 | 186 | PF01048 | 0.710 |
| MOD_GlcNHglycan | 253 | 256 | PF01048 | 0.569 |
| MOD_GSK3_1 | 120 | 127 | PF00069 | 0.514 |
| MOD_GSK3_1 | 194 | 201 | PF00069 | 0.396 |
| MOD_GSK3_1 | 226 | 233 | PF00069 | 0.447 |
| MOD_GSK3_1 | 251 | 258 | PF00069 | 0.557 |
| MOD_GSK3_1 | 309 | 316 | PF00069 | 0.577 |
| MOD_GSK3_1 | 74 | 81 | PF00069 | 0.657 |
| MOD_N-GLC_1 | 74 | 79 | PF02516 | 0.652 |
| MOD_NEK2_1 | 141 | 146 | PF00069 | 0.509 |
| MOD_NEK2_1 | 150 | 155 | PF00069 | 0.488 |
| MOD_NEK2_1 | 194 | 199 | PF00069 | 0.425 |
| MOD_NEK2_1 | 230 | 235 | PF00069 | 0.454 |
| MOD_NEK2_1 | 251 | 256 | PF00069 | 0.559 |
| MOD_NEK2_1 | 79 | 84 | PF00069 | 0.742 |
| MOD_NEK2_2 | 46 | 51 | PF00069 | 0.519 |
| MOD_PKA_2 | 124 | 130 | PF00069 | 0.515 |
| MOD_PKA_2 | 150 | 156 | PF00069 | 0.588 |
| MOD_PKA_2 | 213 | 219 | PF00069 | 0.410 |
| MOD_Plk_1 | 284 | 290 | PF00069 | 0.600 |
| MOD_Plk_1 | 74 | 80 | PF00069 | 0.645 |
| MOD_Plk_4 | 124 | 130 | PF00069 | 0.404 |
| MOD_Plk_4 | 226 | 232 | PF00069 | 0.445 |
| MOD_Plk_4 | 3 | 9 | PF00069 | 0.354 |
| MOD_ProDKin_1 | 134 | 140 | PF00069 | 0.499 |
| MOD_ProDKin_1 | 200 | 206 | PF00069 | 0.559 |
| TRG_ENDOCYTIC_2 | 111 | 114 | PF00928 | 0.358 |
| TRG_ENDOCYTIC_2 | 256 | 259 | PF00928 | 0.427 |
| TRG_ENDOCYTIC_2 | 60 | 63 | PF00928 | 0.396 |
| TRG_ENDOCYTIC_2 | 7 | 10 | PF00928 | 0.382 |
| TRG_ER_diArg_1 | 89 | 92 | PF00400 | 0.643 |
| Protein | Taxonomy | Sequence identity | Coverage |
|---|---|---|---|
| A0A0N0P5K0 | Leptomonas seymouri | 58% | 100% |
| A0A0S4JDC4 | Bodo saltans | 34% | 100% |
| A0A1X0NXD8 | Trypanosomatidae | 45% | 100% |
| A0A3R7MEG1 | Trypanosoma rangeli | 44% | 100% |
| A4HCQ8 | Leishmania braziliensis | 81% | 100% |
| A4I083 | Leishmania infantum | 100% | 100% |
| C9ZV00 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 45% | 100% |
| E9AW47 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
| Q4QBD0 | Leishmania major | 95% | 100% |
| V5ASF5 | Trypanosoma cruzi | 43% | 100% |